Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a new version of the page materials. This reflects a minor update to the page's documentation or release notes rather than content changes.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, indicating a new version of the page has been released. This reflects a deployment update rather than a substantive change to study content or functionality.SummaryDifference0.0%

- Check37 days agoChange DetectedRecruitment status is updated to indicate no longer looking for participants, and new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention/Treatment header has been reformatted for consistency.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page revision was bumped from v3.5.4 to v3.5.5 as a minor maintenance update. This does not alter the study details or other user-facing content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4. This update does not modify study details or data presented on the page.SummaryDifference0.0%

- Check87 days agoChange DetectedA location spelling is corrected so the Parramatta, New South Wales site name is consistent. The page’s revision/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.